Among the most consistently upregulated molecules, miR-21 functions as a central oncogenic driver by targeting tumor suppressors such as PTEN and PDCD4, leading to activation of the PI3K/AKT and MAPK pathways that promote cell survival and chemoresistance. The gene discussed is PTEN; the disease is neoplasm.